Symptoms of social anxiety disorder and major depressive disorder: A network perspective

被引:30
|
作者
Langer, Julia K. [1 ,3 ]
Tonge, Natasha A. [1 ,4 ]
Piccirillo, Marilyn [1 ,4 ]
Rodebaugh, Thomas L. [1 ,4 ]
Thompson, Renee J. [1 ,4 ]
Gotlib, Ian H. [2 ,5 ]
机构
[1] Washington Univ, 1 Brookings Dr, St Louis, MO 63130 USA
[2] Stanford Univ, 450 Serra Mall, Stanford, CA 94305 USA
[3] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN 55417 USA
[4] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63130 USA
[5] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA
关键词
Social anxiety disorder; Treatment; Depression; Assessment; Diagnosis; Anxiety disorders; CROSS-SECTIONAL ANALYSES; DSM-IV DISORDERS; MOOD DISORDERS; COMORBIDITY; PREVALENCE; INVENTORY; LIFETIME; PHOBIA; DIMENSIONS; RISK;
D O I
10.1016/j.jad.2018.09.078
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: We used network analyses to examine symptoms that may play a role in the co-occurrence of social anxiety disorder (SAD) and major depressive disorder (MDD). Whereas latent variable models examine relations among latent constructs, network analyses have the advantage of characterizing direct relations among the symptoms themselves. Method: We conducted network modeling on symptoms of social anxiety and depression in a clinical sample of 130 women who met criteria for SAD, MDD, both disorders, or had no lifetime history of mental illness. Results: In the resulting network, the core symptoms of social fear and depressed mood appeared at opposite ends of the network and were weakly related; so-called "bridges" between these symptoms appeared to occur via intervening variables. In particular, the worthless variable appeared to play a central role in the network. Limitations: Because our data were cross-sectional, we are unable to draw conclusions about the direction of these effects or whether these variables are related to each other prospectively. Conclusions: Continued testing of these pathways using longitudinal data will help facilitate the development of more effective clinical interventions for these disorders.
引用
下载
收藏
页码:531 / 538
页数:8
相关论文
共 50 条
  • [1] Discontinuation symptoms in social anxiety disorder, general anxiety disorder, and major depressive disorder
    Baldwin, DS
    Montgomery, SA
    Nil, R
    Lader, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S425 - S426
  • [2] Discontinuation symptoms in social anxiety disorder, general anxiety disorder, and major depressive disorder.
    Montgomery, SA
    Baldwin, D
    Nil, R
    Lader, M
    NORDIC JOURNAL OF PSYCHIATRY, 2005, 59 (05) : 416 - 416
  • [3] Event centrality in social anxiety disorder and major depressive disorder
    Vermeulen, Mirjam
    Gandhi, Amarendra
    van den Eede, Filip
    Raes, Filip
    Krans, Julie
    MEMORY, 2024, 32 (05) : 528 - 539
  • [4] A network perspective on body dysmorphic disorder and major depressive disorder
    Summers, Berta J.
    Aalbers, George
    Jones, Payton J.
    McNally, Richard J.
    Phillips, Katharine A.
    Wilhelm, Sabine
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 262 : 165 - 173
  • [5] The Centrality of Depression and Anxiety Symptoms in Major Depressive Disorder Determined Using a Network Analysis
    Park, Seon-Cheol
    Kim, Daeho
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 271 : 19 - 26
  • [6] The Centrality of Depression and Anxiety Symptoms in Major Depressive Disorder Determined Using a Network Analysis
    Park, Seon-Cheol
    Kim, Daeho
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S230 - S230
  • [7] Mapping the Presence of Anxiety Symptoms in Adults With Major Depressive Disorder
    Ge, Fenfen
    Jiang, Jingwen
    Wang, Yue
    Wan, Mentong
    Zhang, Wei
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [8] Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
    Thase, Michael E.
    Chen, Dalei
    Edwards, John
    Ruth, Adam
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2014, 29 (06) : 351 - 356
  • [9] Quetiapine - adjunctive treatment of major depressive disorder with anxiety symptoms
    Bise, S.
    Sulejmanpasic, G.
    Begic, D.
    Ahmic, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S851 - S852
  • [10] The network structure of major depressive disorder, generalized anxiety disorder and somatic symptomatology
    Bekhuis, E.
    Schoevers, R. A.
    van Borkulo, C. D.
    Rosmalen, J. G. M.
    Boschloo, L.
    PSYCHOLOGICAL MEDICINE, 2016, 46 (14) : 2989 - 2998